Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Conditions
Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Comprehensive Cancer Center, Duarte, California, United States
Contact: Principal Investigator (Alex Chehrazi-Raffle)UC San Diego Health System - Encinitas, Encinitas, California, United States
Contact: Principal Investigator (Sharon Choi)City of Hope at Irvine Lennar, Irvine, California, United States
Contact: Principal Investigator (Alex Chehrazi-Raffle)UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Principal Investigator (Sharon Choi)UC San Diego Medical Center - Hillcrest, San Diego, California, United States
Contact: Principal Investigator (Sharon Choi)Yale University, New Haven, Connecticut, United States
Contact: Principal Investigator (So Yeon Kim)Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States
Contact: Principal Investigator (So Yeon Kim)UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States
Contact: Principal Investigator (Thomas J. George)Northwestern University, Chicago, Illinois, United States
Contact: Principal Investigator (Pedro Viveiros)University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
Contact: Principal Investigator (Susanne M. Arnold)Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States
Contact: Principal Investigator (Daniel Johnson)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Kartik Sehgal)Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Contact: Principal Investigator (Andrew Davis)Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Contact: Principal Investigator (Andrew Davis)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Andrew Davis)Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Principal Investigator (Andrew Davis)Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (Andrew Davis)NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Alexander Wei)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (David A. Liebner)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Christina Washington)Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, United States
Contact: Principal Investigator (Vicki L. Keedy)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Vicki L. Keedy)M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Funda Meric-Bernstam)University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303Contact: Principal Investigator (Ludimila Cavalcante)VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Contact: Principal Investigator (Andrew Poklepovic)University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
Contact: Principal Investigator (Cheryl M. Czerlanis)University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Principal Investigator (Cheryl M. Czerlanis)
Study leads
Funda Meric-Bernstam
Principal Investigator
University of Texas MD Anderson Cancer Center LAO